Common variant approaches to study Mendelian disease gene function identify novel phenome and pathways associated with PLOD3
The study of rare and common genetic disorders, in terms of study design, methods, and their genetic architecture, has largely been thought of as distinct. As sequencing technologies and analytic methods have advanced, we’ve learned that polygenic background can impact the penetrance, severity, and onset of certain Mendelian conditions. While genome-wide analyses have significantly contributed to our understanding of human disease, these studies rarely explore how common variation within Mendelian disease genes affect phenotypic outcomes. We applied common variant-based approaches in BioVU, Vanderbilt University Medical Center’s electronic health record (EHR)-linked biobank to characterize the phenotypic architecture correlated with PLOD3 , the Mendelian disease gene linked to BCARD syndrome. To characterize the clinical features associated with reduced PLOD3 genetically predicted gene expression (GPGE), we conducted a gene-based phenome-wide association study (PheWAS) in BioVU. We compared this gene-based phenome to the human phenotype ontology features of BCARD syndrome and incorporated these overlapping, yet distinct patterns into phenotype risk scores (PheRS). The PheRS from the Mendelian features of BCARD syndrome and the PheRS constructed from our gene-based PheWAS were used to implement transcriptome-wide association studies (TWAS) to expand the genetic and pathway level associations for PLOD3 -mediated biology. We found that reduced PLOD3 GPGE derived from common genetic variation, can capture clinical features linked to BCARD syndrome, and to phenotypes not previously associated with PLOD3 . These phenotype associations were replicated with a protein quantitative trait locus (pQTL) for PLOD3 and identity by descent analysis of the PLOD3 locus. TWAS associations with the Mendelian and PLOD3 gene-based PheRS’s identified an enrichment of metabolic pathways ( p < 0.05). This study implements a scalable approach using EHR-based clinical features and GPGE to identify phenotypic architecture and use it as a tool for expanding gene and pathway associations with Mendelian disease genes. By using both PheRSs in TWAS, we identified an enrichment of metabolic and skeletal development related pathways ( p < 0.05), highlighting a potential novel and druggable mechanism. The application of these common variant -based approaches at biobank scale to other Mendelian disease genes has the potential to aid in drug repurposing and identify candidate therapeutic targets.
Authors
- David C. Samuels (ORCID: https://orcid.org/0000-0003-3529-7791)
- Tyne W. Miller‐Fleming (ORCID: https://orcid.org/0000-0002-0398-5162)
- Jennifer Elizabeth Below (ORCID: https://orcid.org/0000-0002-1346-1872)
- Nancy Jean Cox (ORCID: https://orcid.org/0000-0001-9315-0830)
- Megan M. Shuey (ORCID: https://orcid.org/0000-0003-2866-3562)
- Alexandra Scalici (ORCID: https://orcid.org/0000-0003-2336-685X)
- Freida Blostein (ORCID: https://orcid.org/0000-0002-5734-4969)
- James T. Baker
- Ela W. Knapik (ORCID: https://orcid.org/0000-0002-2977-3619)
- Lisa A. Bastarache (ORCID: https://orcid.org/0000-0003-3020-447X)
Institutions
- Vanderbilt University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Genome Medicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1186/s13073-026-01822-8
- Primary Topic
- Genetic Associations and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vanderbilt University
- Vanderbilt University Medical Center
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- National Institute of General Medical Sciences
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development